"synopsis" may belong to another edition of this title.
From the reviews:
"People running cancer trials should read this book. It is about the US National Cancer Institute’s plans to ‘liberate cancer trials from paper’. ... The chapters were written by leading US experts. The content is detailed, technical, and surprisingly well-written. They give a clear vision of how cancer trials are likely to develop over the next 20 years. This book is informative, interesting, and ... enjoyable." (M Stockler, Cancer Forum, Vol. 27 (3), 2003)
"About this title" may belong to another edition of this title.
Shipping:
US$ 49.00
From Germany to U.S.A.
Book Description Pp. Condition: Neu. Gebraucht - Sehr gut has some shelf wear; ungelesen, sehr guter Zustand; Rechnung mit MwSt.; unused/unread, very good condition; 408 pp. Englisch. Seller Inventory # INF1000337966
Book Description Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEOCT23-78802
Book Description Condition: New. Brand New Original US Edition.We Ship to PO BOX Address also. EXPEDITED shipping option also available for faster delivery.This item may ship from the US or other locations in India depending on your location and availability. Seller Inventory # ABTR-217380
Book Description Condition: New. Brand New Original US Edition. Customer service! Satisfaction Guaranteed. This item may ship from the US or our Overseas warehouse depending on your location and stock availability. We Ship to PO BOX Location also. Seller Inventory # ABRR-217380
Book Description Hardcover. Condition: new. Seller Inventory # 9780387953281
Book Description Condition: New. Seller Inventory # ABLIING23Feb2215580174500
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9780387953281_lsuk
Book Description Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Cancer Informatics chronicles the development of the National Cancer Institute's new Cancer Informatics Infrastructure (CII) - an information management system infrastructure designed to faciliate clinical trials, provide for reliable, secure information exchange, and improve patient care. The book details the challenges involved in creating and managing such a knowledge base, including technologies, standards, and current, state-of-the-art applications.The ultimate goal of CII is to function as an enabler of clinical trials, expediting the clinical trials lifecycle, faciliating faster and safer drug development and more appropriate treatment choices for cancer patients. Contributors address the role the CII must play in converting the growing knowledge of genes, proteins, and pathways into appropriate preventative, diagnostic, and therapeutic measures. Presented in four sections, the first provides an overview of the processes involved in moving the infrastructure for cancer from theory into practice. Sections two through four offer the latest work done in the areas of technology, cancer-specific and national standards, and applications to faciliate clinical trials. 408 pp. Englisch. Seller Inventory # 9780387953281
Book Description Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Cancer Informatics chronicles the development of the National Cancer Institute s new Cancer Informatics Infrastructure (CII) - an information management system infrastructure designed to faciliate clinical trials, provide for reliable, secure informa. Seller Inventory # 5912469
Book Description Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Cancer Informatics chronicles the development of the National Cancer Institute's new Cancer Informatics Infrastructure (CII) - an information management system infrastructure designed to faciliate clinical trials, provide for reliable, secure information exchange, and improve patient care. The book details the challenges involved in creating and managing such a knowledge base, including technologies, standards, and current, state-of-the-art applications.The ultimate goal of CII is to function as an enabler of clinical trials, expediting the clinical trials lifecycle, faciliating faster and safer drug development and more appropriate treatment choices for cancer patients. Contributors address the role the CII must play in converting the growing knowledge of genes, proteins, and pathways into appropriate preventative, diagnostic, and therapeutic measures. Presented in four sections, the first provides an overview of the processes involved in moving the infrastructure for cancer from theory into practice. Sections two through four offer the latest work done in the areas of technology, cancer-specific and national standards, and applications to faciliate clinical trials. Seller Inventory # 9780387953281